- Home
- IPHA vs LGI Comparison
IPHA vs LGI Comparison
Compare IPHA & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- LGI
- Stock Information
- Founded
- IPHA 1999
- LGI 2004
- Country
- IPHA France
- LGI United States
- Employees
- IPHA N/A
- LGI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- IPHA Health Care
- LGI
- Exchange
- IPHA Nasdaq
- LGI Nasdaq
- Market Cap
- IPHA 160.1M
- LGI 189.3M
- IPO Year
- IPHA 2019
- LGI N/A
- Fundamental
- Price
- IPHA $2.38
- LGI $15.58
- Analyst Decision
- IPHA Strong Buy
- LGI
- Analyst Count
- IPHA 1
- LGI 0
- Target Price
- IPHA $11.00
- LGI N/A
- AVG Volume (30 Days)
- IPHA 31.8K
- LGI 41.1K
- Earning Date
- IPHA 03-27-2025
- LGI 01-01-0001
- Dividend Yield
- IPHA N/A
- LGI 7.10%
- EPS Growth
- IPHA N/A
- LGI N/A
- EPS
- IPHA N/A
- LGI N/A
- Revenue
- IPHA $20,831,349.00
- LGI N/A
- Revenue This Year
- IPHA $209.83
- LGI N/A
- Revenue Next Year
- IPHA $83.96
- LGI N/A
- P/E Ratio
- IPHA N/A
- LGI N/A
- Revenue Growth
- IPHA N/A
- LGI N/A
- 52 Week Low
- IPHA $1.29
- LGI $12.66
- 52 Week High
- IPHA $3.51
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- IPHA 71.42
- LGI 59.82
- Support Level
- IPHA $2.13
- LGI $15.34
- Resistance Level
- IPHA $2.34
- LGI $15.68
- Average True Range (ATR)
- IPHA 0.14
- LGI 0.26
- MACD
- IPHA 0.04
- LGI 0.13
- Stochastic Oscillator
- IPHA 90.07
- LGI 94.22
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.